Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Genetic variants for vitamin D deficiency were not associated with celiac disease (odds ratio per risk allele of the child, 1.00; 95% CI, 0.90 to 1.10, odds ratio per risk allele of the mother 0.94; 95% CI 0.85 to 1.04).

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Multiple reported designs.

Multiple reported designs

More than one design is explicitly reported; examine the supporting methods.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Mothers and children were genotyped for established celiac disease and vitamin D metabolism variants.

Source: Abstract.

We designed a case-control study nested within the Norwegian Mother and Child Cohort Study (MoBa).

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Maternal and neonatal vitamin D status, genotype and childhood celiac disease

Multiple reported designs · PLoS ONE · 2017

Original publication title

Maternal and neonatal vitamin D status, genotype and childhood celiac disease

Karl Mårild; German Tapia; Margareta Haugen; Sandra R. Dahl; Arieh S. Cohen; Marika Lundqvist; Benedicte A. Lie; Lars C. Stene; Ketil Størdal

© 2017 Mårild et al

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

We found no support for the hypothesis that maternal or neonatal vitamin D status is related to the risk of childhood celiac disease.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Low concentration of 25-hydroxyvitamin D during pregnancy may be associated with offspring autoimmune disorders. Little is known about environmental triggers except gluten for celiac disease, a common immune-mediated disorder where seasonality of birth has been reported as a risk factor. We therefore aimed to test whether low maternal and neonatal 25-hydroxyvitamin D predicted higher risk of childhood celiac disease.

Source: Background

Abstract: Methods and Findings

In this Norwegian nationwide pregnancy cohort (n = 113,053) and nested case-control study, we analyzed 25-hydroxyvitamin D in maternal blood from mid-pregnancy, postpartum and cord plasma of 416 children who developed celiac disease and 570 randomly selected controls. Mothers and children were genotyped for established celiac disease and vitamin D metabolism variants. We used mixed linear regression models and logistic regression to study associations.

There was no significant difference in average 25-hydroxyvitamin D between cases and controls (63.1 and 62.1 nmol/l, respectively, p = 0.28), and no significant linear trend (adjusted odds ratio per 10 nM increase 1.05, 95% CI: 0.93 to 1.17). Results were similar when analyzing the mid-pregnancy, postpartum or cord plasma separately. Genetic variants for vitamin D deficiency were not associated with celiac disease (odds ratio per risk allele of the child, 1.00; 95% CI, 0.90 to 1.10, odds ratio per risk allele of the mother 0.94; 95% CI 0.85 to 1.04).

Vitamin D intake in pregnancy or by the child in early life did not predict later celiac disease. Adjustment for established genetic risk markers for celiac disease gave similar results.

Source: Methods and Findings Source: Methods and Findings

Abstract: Conclusions

We found no support for the hypothesis that maternal or neonatal vitamin D status is related to the risk of childhood celiac disease.

Source: Conclusions
Authors’ abstract

Background

Low concentration of 25-hydroxyvitamin D during pregnancy may be associated with offspring autoimmune disorders. Little is known about environmental triggers except gluten for celiac disease, a common immune-mediated disorder where seasonality of birth has been reported as a risk factor. We therefore aimed to test whether low maternal and neonatal 25-hydroxyvitamin D predicted higher risk of childhood celiac disease.

Methods and Findings

In this Norwegian nationwide pregnancy cohort (n = 113,053) and nested case-control study, we analyzed 25-hydroxyvitamin D in maternal blood from mid-pregnancy, postpartum and cord plasma of 416 children who developed celiac disease and 570 randomly selected controls. Mothers and children were genotyped for established celiac disease and vitamin D metabolism variants. We used mixed linear regression models and logistic regression to study associations.

There was no significant difference in average 25-hydroxyvitamin D between cases and controls (63.1 and 62.1 nmol/l, respectively, p = 0.28), and no significant linear trend (adjusted odds ratio per 10 nM increase 1.05, 95% CI: 0.93 to 1.17). Results were similar when analyzing the mid-pregnancy, postpartum or cord plasma separately. Genetic variants for vitamin D deficiency were not associated with celiac disease (odds ratio per risk allele of the child, 1.00; 95% CI, 0.90 to 1.10, odds ratio per risk allele of the mother 0.94; 95% CI 0.85 to 1.04).

Vitamin D intake in pregnancy or by the child in early life did not predict later celiac disease. Adjustment for established genetic risk markers for celiac disease gave similar results.

Conclusions

We found no support for the hypothesis that maternal or neonatal vitamin D status is related to the risk of childhood celiac disease.

Publication and source details

Original title: Maternal and neonatal vitamin D status, genotype and childhood celiac disease

Karl Mårild; German Tapia; Margareta Haugen; Sandra R. Dahl; Arieh S. Cohen; Marika Lundqvist; Benedicte A. Lie; Lars C. Stene; Ketil Størdal

PLoS ONE · 2017

Competing Interests: The authors have declared that no competing interests exist.

  • Conceptualization: KS LCS.

  • Data curation: KS LCS KM GT MH.

  • Formal analysis: KS LCS KM GT.

  • Funding acquisition: KS LCS.

  • Investigation: SRD ASC ML BAL KS LCS.

  • Methodology: KS LCS.

  • Project administration: KS LCS.

  • Resources: SRD ASC ML BAL KS LCS.

  • Software: KS LCS GT.

  • Supervision: KS LCS.

  • Validation: KS LCS KM.

  • Visualization: KS GT LCS.

  • Writing: original draft: KS.

  • Writing: review & editing: KM GT MH SRD ASC ML BAL LCS KS.

* E-mail: ketil.stordal@fhi.no
© 2017 Mårild et al2017Mårild et alhttps://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.http://dx.doi.org/10.13039/100000065National Institute of Neurological Disorders and StrokeUO1 NS 047537-01http://dx.doi.org/10.13039/100000065National Institute of Neurological Disorders and StrokeUO1 NS 047537-06A1http://dx.doi.org/10.13039/100000066National Institute of Environmental Health SciencesN01-ES-75558http://dx.doi.org/10.13039/501100005416Norges ForskningsrådStene Lars C. Oak Foundation, Geneva, SwitzerlandKetil StordalThe Norwegian Mother and Child Cohort Study is supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research, NIH/NIEHS (contract no N01-ES-75558), NIH/NINDS (grant no.1 UO1 NS 047537-01 and grant no.2 UO1 NS 047537-06A1). The sub-study was funded by a research grant from the Research Council of Norway. Dr Størdal was supported by an unrestricted grant from Oak Foundation, Geneva, Switzerland.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T23:15:47.010266+00:00

DOI: 10.1371/journal.pone.0179080 · PMC5501391